Genetic and environmental factors in head and neck cancer genesis

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 26, Issue 2, 2008, Pages 174-200

  Báez, Adriana ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Alcohol; Epidemiology; Etiology; Genetic susceptibility; Head and neck cancer; Human papilloma virus; Occupational; Risk factors; Smoking

Indexed keywords

ETHANOL; LITHIUM; NUCLEIC ACIDS; ORGANIC ACIDS;

ATAXIA TELANGIECTASIA; BLOOM SYNDROME; CURRENT STATUS; DNA REPAIR; ENVIRONMENTAL FACTORS; ETHANOL CONSUMPTION; HEAD AND NECK CANCER (HNC); HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC); ORAL CAVITIES; PAPILLOMA VIRUSES; SQUAMOUS CELL CARCINOMAS (SCC); TOXIC SUBSTANCES;

HEALTH;

ALCOHOL; CARCINOGEN; DNA; ENZYME; TOXIC SUBSTANCE;

ALCOHOL CONSUMPTION; BLOOM SYNDROME; CANCER GENETICS; CANCER RISK; CARCINOGENESIS; CAUSAL ATTRIBUTION; DIET; DNA REPAIR; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; FAMILIAL CANCER; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEAD AND NECK CARCINOMA; HEREDITY; HUMAN; LIFESTYLE; NONHUMAN; OCCUPATIONAL HAZARD; PROGNOSIS; REVIEW; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; TOBACCO; VIRUS INFECTION; WART VIRUS; XENOBIOTIC METABOLISM; ENVIRONMENT; GENETICS; HEAD AND NECK TUMOR;

ATAXIA TELANGIECTASIA; HUMAN PAPILLOMAVIRUS; NICOTIANA TABACUM; PAPILLOMAVIRIDAE;

CARCINOMA, SQUAMOUS CELL; ENVIRONMENT; HEAD AND NECK NEOPLASMS; HUMANS; LIFE STYLE; PROGNOSIS; RISK FACTORS;

EID: 46749142078     PISSN: 10590501     EISSN: 15324095     Source Type: Journal    
DOI: 10.1080/10590500802129431     Document Type: Review

References (235)

1. Myers EN, Suen JY. Cancer of the Head and Neck, 4th ed., Philadelphia, London: WB Saunder, 2003.
2. Dhooge IJ, DeVos M, Van Cauwenberge PB. Multiple primary malignant tumors in patients with head and neck cancer, results of prospective study and future perspectives. Laryngoscope 1998;108(2):250-6.
3. de Bree R, Deurloo EE, Snow GB, Leemans CR. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000;110(3 Pt 1):397-401.
4. Jovanovic A, van der Tol IG, Schulten EA, Kostense PJ, de Vries N, Snow GB, van der Waal I. Risk of multiple primary tumors following oral squamous-cell carcinoma. Int J Cancer 1994;56(3):320-3.
5. Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: (1994) The overshadowing threat for patients with early-stage disease. Int J Rad Oncol Biol Phys 1989;17(3):691-4.
6. Cooper JS, Pajak TF, Rubin P, Rubin P, Tupchong L, Brady LW, Leibel SA, Laramore GE, Marcial VA, Davis LW, et al. Second malignancies in patients who have head and neck cancers: incidence, effect on survival and implications for chemoprevention based on the RTOG experience. Int J Rad Oncol Biol Phys 1989;71(3):449-56.
7. Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J. Second neoplasm in patients with head and neck cancer. Head Neck 1999;21(3):204-10.
8. Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman SM, Fu KK, Cooper JS, Vokes EE, Chamberlain RM, Williams B, Pajak TF, Goepfert H, Hong WK. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev 2001;10(8):823-29.
9. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953;6(5):963-8.
10. Wynder EL, Covey LS, Mabuchi K, Mushinski M. Environmental factors in cancer of the larynx: a second look. Cancer 1976;38(4):1591-601.
11. Chung KY, Mukhop AD, Hyay T, Casson A, Ro JY, Geopfert H, Hong WK, Roth JA. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993;53(7):1676-83.
12. Nees M, Homann N, Discher H, Andl T, Endrs C, Herold-Mende C, Schuhmann A, Bosch FX. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patient: A possible molecular basis for the development of multiple tumors. Cancer Res 1993;53(18):4189-96.
13. Harris MJ, Coggan M, Langton L, Wilson SR, Board PG. Polymorphism of the Pi class glutathione-S-transferase in normal populations and cancer patients. Pharmacogenetics 1998;8(1):27-31.
14. Scholes AG, Woolgar JA, Boyle MA, Brown JS, Vaughan ED, Hart CA, Jones AS, Field JK. Synchronous oral carcinomas: independent or common clonal origin? Cancer Res 1998;58(9):2003-6.
15. Hiroshima K, Toyozaki T, Kohno H, Ohwada H, Fujisawa T. Synchronous and metachronous lung carcinomas: molecular evidence for multicentricity. Pathol Int 1998;48(11):869-76.
16. Jang SJ, Chiba I, Hirai A, Hong WK, Mao L. Multiple oral squamous epithelial lesions: Are they genetically related? Oncogene 2001;20(18):2235-42.
17. Spitz MR. Epidemiology and risk factors for head and neck cancer. Semin Oncol 1994;21(3):281-8.
18. Cloos J, Braakhuos BJM, Steen I, Copper MP, de Vries N, Nauta JJP, Snow GB. Increased mutagen sensitivity in head-and-neck squamous-cell carcinoma patients, particularly those with multiple primary tumors. Int. J. Cancer 1994;56(6):816-9.
19. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 1996;56(11):2484-7.
20. Bjordal K, Ahlner-Elmqvist M, Hammerlid E, Boysen M, Evensen JF, Biörklund A, Jannert M, Westin T, Kaasa S. A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope 2001;11(8):1440-52.
21. Terrell JE, Ronis DL, Fowler KE, Bradford CR, Chepeha DB, Prince ME, Teknos TN, Wolf GT, Duffy SA. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130(4):401-8.
22. Taylor JC, Terrell JE, Ronis DL, Fowler KE, Bishop C, Lambert MT, Myers LL, Duffy SA, Bradford CR, Chepeha DB, Hogikyan ND, Prince ME, Teknos TN, Wolf GT, University of Michigan Head and Neck Cancer Team. Disability in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130(6):764-9.
23. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55(2):74-108.
24. American Cancer Society. Cancer Facts and Figures 2007 Atlanta, American Cancer Society 2007.
25. Sellers TA, Potter JD, Bailey-Wilson JE, Rich SS, Rothschild H, Elston RC. Lung cancer detection and prevention: evidence of interaction between smoking and genetic predisposition. Cancer Res 1992;52(9 Suppl):2694-7.
26. Brandsma JL, Abramson AL. Association of papilloma viruses with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 1989;115(5):621-5.
27. Franceschi S, Bidoli P, Herrero R, Munoz N. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol 2000;36(1):106-15.
28. Sturgis, EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers. Cancer 2007;110(7):1429-35.
29. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni JF Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48(11):3282-7.
30. Tuyns AJ, Esteve J, Raymond L, Berrino F, Benhamou E, Blanchet F, Boffetta P, Crosignani P, del Moral A, Lehmann W, et al. Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer 1988;41(4):483-91.
31. Macigo FG, Mwaniki DL, Guthua SW. Influence of dose and cessation of kiraiku, cigarettes and alcohol use on the risk of developing oral leukoplakia. Eur J Oral Sciences 1996;104(5-6):498-02.
32. Saracci R. The interactions of tobacco smoking and other agents in cancer etiology. Epidemiol Rev 1987;9:175-93.
33. Muscat JE, Wynder EL. Tobacco, alcohol, asbestos and occupational risk factors for laryngeal cancer. Cancer 1992;69(9):2244-51.
34. McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer, epidemiology and molecular biology. Head Neck 1998;20(3):250-65.
35. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92(9):709-20.
36. Rothman KJ, Cann CI, Flanders D, Fried MP. Epidemiology of laryngeal cancer. Epidemiol 1980;2:195-209.
37. Doll, R. Uncovering the effects of smoking: Historical perspective. Stat. Methods Med. Res 1998;7(2):87-117.
38. International Agency for Research on Cancer. Tobacco smoking. IARC Monograph on the evaluation of carcinogenic risks of chemicals to humans. IARC, Lyon, France 1986;38:1-397.
39. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC, Lyon, France. 2004;83:59-80.
40. International Agency for Research on Cancer. Alcohol drinking. IARC Monograph on the evaluation of carcinogenic risks of chemicals to humans. IARC: Lyon, France 1989;40:1-444.
41. Wynder EL, Stellman SD. Impact of long-term filter cigarette usage on lung and larynx cancer risk: a case-control study. J Natl Cancer Inst 1979;62(3):471-7.
42. Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman SM, Fu KK, Cooper JS, Vokes EE, Chamberlain RM, William SB, Pajak TF, Geopfert H, Hong WK. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev 2001;10(8):823-9.
43. Spitz MR, Fueger JJ, Goepfert H, Hong WK, Newell GR. Squamous cell carcinoma of the upper aerodigestive tract. A case comparison analysis. Cancer 1988;61(1):203-8.
44. Muscat JE, Richie JP, Thompson S, Wynder EL. Gender differences in smoking and risk for oral cancer. Cancer Res 1996;56(22):5192-7.
45. Wynder EL, Bross JJ, Day E. A study of environmental factors in cancer of the larynx. Cancer 1956;9(1):86-110.
46. Talamini R, La Vecchia C, Levi F, Conti E, Favero A, Franceschi S. Cancer of the oral cavity and pharynx in nonsmokers who drink alcohol and in nondrinkers who smoke tobacco. J Natl Cancer Inst 1998;90(24):1901-3.
47. Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst. 2007;99(10):777-89.
48. Hecht SS. Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke. Tob Control 2004;13(1 Suppl):48-56.
49. Hedley AJ, McGhee SM, Repace JL, Wong LC, Yu MY, Wong TW, Lam TH. Risks for heart disease and lung cancer from passive smoking by workers in the catering industry. Toxicol Sci 2006;90(2):539-48.
50. Hill SE, Blakely T, Kawachi I, Woodward A. Mortality among lifelong nonsmokers exposed to secondhand smoke at home: cohort data and sensitivity analyses. Am J Epidemiol 2007;165(5):530-40.
51. International Agency for Research on Cancer. Smokeless tobacco and tobacco-specific nitrosamines. Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC, Lyon, France 2007;89.
52. Johnson GK, Squier CA. Smokeless tobacco use by youth: a health concern. Pediatr Dent. 1993;15(3):169-74.
53. Vogler WR, Lloyd JW, Milmore BK. A retrospective study of etiological factors in cancer of the mouth, pharynx, and larynx. Cancer 1962;15:246-58.
54. Mashberg A, Boffetta P, Winkelman R, et al. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993;72(4):1369-75.
55. Ghosh S, Shukla HS, Mohapatra SC, Shukla PK. Keeping chewing tobacco in the cheek pouch overnight (night quid) increases risk of cheek carcinoma. Eur J Surg Oncol 1996;22(4):359-60.
56. Lewin F, Norell SE, Gustavsson P, Wennerberg J, Biörklund A, Rutqvist LE. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck. A population-based case-referent study in Sweden. Cancer 1998;82(7):1367-75.
57. Roosaar A, Johansson AL, Sandborgh-Englund G, Nyrén O, Axéll T. A long-term follow-up study on the natural course of snus-induced lesions among Swedish snus users. Int J Cancer 2006;119(2):392-7.
58. Winn DM, Blot WJ, Shy CM, Pickle LW, Toledo MA, Fraumeni JF Jr. Snuff dipping and oral cancer among women in the Southern United States. N. Engl. J. Med 1981;304(13):745-9.
59. Rosenquist K, Wennerberg J, Schildt EB, Bladström A, Hansson BG, Andersson G. Use of Swedish moist snuff, smoking and alcohol consumption in the aetiology of oral and oropharyngeal squamous cell carcinoma population-based case-control study in southern Sweden. Acta Otolaryngol 2005;125(9):991-8.
60. Luo J, Ye W, Zendehdel K, Adami J, Adami HO, Boffetta P, Nyrén O. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007;369(9578):1976-8.
61. Weitkunat R, Sanders E, Lee PN. Meta-analysis of the relation between European and American smokeless tobacco and oral cancer. BMC Public Health 2007;7(147):334.
62. Nair J, Ohshima H, Nair UJ, Bartsch H. Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users. Crit Rev Toxicol 1996;26(2):149-61.
63. Hecht SS, Carmella SG, Murphy SE, Riley W, Le C, Luo X, Mooney M, Hatsukami DK. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiol Biomarkers Prev 2007;16(8):1567-72.
64. Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst 1998;90(16):1198-205.
65. Silverman S Jr. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 2001;132 suppl:7S-11S.
66. Zhang ZF, Morgenstern H, Spitz MR, Toshkin DP, Yu GP, Marshall JR, Hsu TC, Schantz SP. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 1999;8(12):1071-8.
67. Schantz SP, Yu GP. Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 2002;128(3):268-74.
68. Rosenblatt KA, Daling JR, Chen C, Sherman KJ, Schwartz SM. Marijuana use and risk of oral squamous cell carcinoma. Cancer Res 2004;64(11):4049-54.
69. Hashibe M, Morgenstern H, Cui Y, Tashkin DP, Zhang ZF, Cozen W, Mack TM, Greenland S. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2006;15(10):1829-34.
70. Centers for Disease Control and Prevention. Bidi use among urban youth - Massachusetts, March-April 1999. Morbidity and Mortality Weekly Report 1999;282(15):1416-17.
71. Yen KL, Hechavarria E, Bostwick SB. Bidi Cigarettes: An Emerging Threat to Adolescent Health. Archives Pediatrics & Adolescent Medicine 2000;154(12):1187-9.
72. Dikshit RP, Kanhere S. Tobacco habits and risk of lung, oropharyngeal and oral cavity cancer: a population-based case-control study in Bhopal, India. Int J Epidemiol 2000;29(4):609-14.
73. Rahman M, Sakamoto J, Fukui T. Bidi smoking and oral cancer: a meta-analysis. Int J Cancer 2003;106(4):600-04.
74. Wu W, Song S, Ashley DL, Watson CH. Assessment of tobacco-specific nitrosamines in the tobacco and mainstream smoke of Bidi cigarettes. Carcinogenesis 2004;25(2):283-7.
75. Subapriya R, Thangavelu A, Mathavan B, Ramachandran CR, Nagini S. Assessment of risk factors for oral squamous cell carcinoma in Chidambaram, Southern India: a case-control study. Eur J Cancer Prev 2007;16(3):251-6.
76. Nair J, Nair UJ, Ohshima H, Bhide SV, Bartsch H. Endogenous nitrosation in the oral cavity of chewers while chewing betel quid with or without tobacco. IARC Sci Publ 1987;84:465-469.
77. International Agency on the Research of Cancer (IARC). Polynuclear aromatic compounds, part 1, chemical, environmental, and experimental data. IARC Monograph on the evaluation of carcinogenic risks of chemicals to humans. Lyon (France): IARC 1983;32:37-38.
78. Rubin H. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis 2001;22(12):1903-30.
79. Cavalieri EL, Rogan EG. Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica 1995;25:677-88.
80. Weinstein IB, Jeffrey AM, Jennette KW, Blobstein SH, Harvey RG, Harris C, Autrup H, Kasai H, Nakanishi K. Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. Science 1976;193:592-5.
81. Perera FP, Santella RM, Brenner D, Poirier MC, Munshi AA, Fischman HK, Van Ryzin J. DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers. J Natl Cancer Inst 1987;79(3):449-56.
82. Poirier MC. Chemical induced DNA damage and human cancer risk Nat Rev Cancer 2004;4(8):630-7.
83. LiD, Wang LE, Chang P, El-Naggar AK, Sturgis EM, Wei Q. In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck. Cancer Res 2007;67(12):5628-34
84. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 1996;274:430-2.
85. Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Cancer Epidemiol Biomarkers Prev 1999;8(4 Pt 1):297-302.
86. Hussain SP, Amstad P, Raja K, Sawyer M, Hofseth L, Shields PG, Hewer A, Phillips DH, Ryberg D, Haugen A, Harris CC. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung. Cancer Res 2001;61(17):6350-5.
87. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002;21(48):7435-51.
88. Hoffmann D, Rivenson A, Chung FL, Hecht SS. Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis. Crit Rev Toxicol 1991;21(4):305-11.
89. Maser E. Significance of reductases in the detoxification of the tobacco-specific carcinogen NNK. Trends Pharmacol Sci 2004;25(5):235-7.
90. Akopyan G, Bonavida B. Understanding tobacco smoke carcinogen NNK and lung tumorigenesis. Int J Oncol 2006;29(4):745-52.
91. Nair J, Ohshima H, Friesen M, Croisy A, Bhide SV, Bartsch H. Tobacco-specific and betel nut-specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis 1985;6(2):295-303.
92. Kresty LA, Carmella SG, Borukhova A, Akerkar SA, Gopalakrishnan R, Harris RE, Stoner GD, Hecht SS. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia. Cancer Epidemiol Biomarkers Prev 1996;5(7):521-5.
93. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991;351(6326):453-6.
94. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253(5015):49-53.
95. http://p53.free.fr/Database/p53 database.html
96. Vogelstein B, Kinzler KW. Carcinogens leave fingerprints. Nature 1992;355(6357):209-10.
97. Nylander K, Dabelsteen E, Hall PA. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 2000;29(9):413-25.
98. Boyle JO, Hakim J, Koch W, Van der Reit P, Hruban RH, Roa RA, Correo R, Eby YJ, Ruppert JM, Sidransky D. The incidence of p53 mutations increase with progression of head and neck cancer. Cancer Res 1993;53(19):4477-80.
99. Fogel S, Ahomadegbe JC, Barrois M, LeBihan ML, Douc-Rasy S, Duvillard P, Armand JP, Riou G. High incidence of p53 mutations in primary and metastatic head and neck tumors. Frequent protein overexpression in normal epithelium. Bull Cancer 1996;83(3):227-33.
100. Liloglou T, Scholes AG, Spandidos DA, Vaughan ED, Jones AS, Field JK. p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability. Cancer Res 1997;57(18):4070-4.
101. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Couch MJ, Forastiere AA, Sidransky D. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332(11):712-7.
102. Kiuru A, Servomaa K, Grénman R, Pulkkinen J, Rytömaa T. p53 mutations in human head and neck cancer cell lines. Acta Otolaryngol Suppl. 117 1997;529:237-40.
103. Rajalingam K, Schreck R, Rapp UR, Albert S. Ras oncogenes and their downstream targets. Biochim Biophys Acta. 2007;1773(8):1177-95.
104. Chang SE, Bhatia P, Johnson NW, Morgan PR, McCormick F, Young B, Hiorns L. Ras mutations in United Kingdom examples of oral malignancies are infrequent. Int J Cancer 1991;48(3):409-12.
105. Sakai E, Rikimaru K, Ueda M, Matsumoto Y, Ishii N, Enomoto S, Yamamoto H, Tsuchida N. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma. Int J Cancer 1992;52(6):867-72.
106. Das N, Majumder J, DasGupta UB. ras gene mutations in oral cancer in eastern India. Oral Oncol. 2000;36(1):76-80.
107. Tuyns AJ. Epidemiology of alcohol and cancer. Cancer Res 1979;39:2840-3.
108. Tuyns AJ. Oesophageal cancer in non-smoking drinkers and in non-drinking smokers. Int J Cancer 1983;32(4):443-4.
109. Elwood JM, Pearson JCG, Skippen DH, Jackson SM. Alcohol, smoking, social and occupational factors in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Cancer 1984;34:603-612.
110. Brugere J, Guenel P, Leclerc A, Rodriguez J. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx and mouth. Cancer. 1986;57(2):391-5.
111. Maier H, Weidauer H, Zöller J, Seitz HK, Flentje M, Mall G, Born IA. Effect of chronic alcohol consumption on the morphology of the oral mucosa. Alcoholism: Clinical and Experimental Research 1994;18(2):387-91.
112. Talamini R, La Vecchia C, Levi F, Conti E, Favero A, Franceschi S. Cancer of the oral cavity and pharynx in nonsmokers who drink alcohol and in nondrinkers who smoke tobacco. J Nat Cancer Inst 1986;90:1901-03.
113. Doll R, Forman D, La Vecchia C. Alcoholic beverages and cancers of the digestive tract and larynx. In: Health Issues Related to Alcohol Consumption, 2nd ed., MacDonald I., ed. pp. 351-393. Oxford: ILSI Europe-Blackwell Science, 1999.
114. Gronbaek M, Becker U, Johansen D, Tonnesen H, Jensen G, Sorensen TI. Population-based cohort study of the association between alcohol intake and cancer of the upper digestive tract. BMJ 1998;317:844-48.
115. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. Alcohol consumption and the risk of cancer: a meta-analysis. Alcohol Res Health. 2001;25(4):263-70.
116. Barra S, Franceschi S, Negri E, Talamini R, La Vecchia C. Type of alcoholic beverage and cancer of the oral cavity, pharynx and oesophagus in an Italian area with high wine consumption. Int. J. of Cancer 1990;46:1017-20.
117. Altieri A, Garavello W, Bosetti C, Gallus S, La Vecchia C. Alcohol consumption and risk of laryngeal cancer. Oral Oncol. 2005;41(10):956-65.
118. Ketcham AS, Wexler H, Mantel N. Effects of alcohol in mouse neoplasia. Cancer Res 1963;23:667-670.
119. Riedel F, Goessler U, Hörmann K. Alcohol-related diseases of the mouth and throat. Best Pract Res Clin Gastroenterol. 2003;17(4):543-55.
120. Seitz HK, Matsuzaki S, Yokoyama A, Homann N, Vakevainen S, Wang XD. Alcohol and Cancer. Alcohol Clin Exp Res 2001;25:137-143.
121. Burton A. Acetaldehyde links alcohol consumption to cancer. Lancet Oncol 2005;6(9):643.
122. Seitz HK, Gärtner U, Egerer G, Simanowski UA. Ethanol metabolism in the gastrointestinal tract and its possible consequences. Alcohol Alcohol Suppl. 1994;2:157-162.
123. Homann N, Jousimies-Somer H, Jokelainen K, Heine R, Salaspuro M. High acetaldehyde levels in saliva after ethanol consumption: methodological aspects and pathogenetic implications. Carcinogenesis 1997;18(9):1739-43.
124. Jokelainen K, Heikkonen E, Roine R, Lehtonen H, Salaspuro M. Increased acetaldehyde production by mouthwashings from patients with oral cavity, laryngeal, or pharyngeal cancer. Alcohol Clin Exp Res. 1996;20(7):1206-10.
125. Obe G, Jonas R, Schmidt S. (1986). Metabolism of ethanol in vitro produces a compound which induces sister-chromatid exchanges in human peripheral lymphocytes in vitro: Acetaldehyde not ethanol is mutagenetic. Mutat Res. 1986;174(1):47-51.
126. Dellarco, VL. A mutagenicity assessment of acetaldehyde. Mutat Res. 1988;195:1-20.
127. Helander A, Lindahl-Kiessling K. Increased frequency of acetaldehyde-induced sister-chromatid exchanges in human lymphocytes treated with an aldehyde dehydrogenase inhibitor. Mutat Res 1991;264:103-107.
128. Fang JL, Vaca CE. Detection of DNA adducts of acetaldehyde in peripheral white blood cells of alcohol abusers. Carcinogenesis 1997;18:627-32.
129. International Agency for Research on Cancer. Allyl compounds, aldehydes, epoxides and peroxides. IARC Monograph on the evaluation of carcinogenic risks of chemicals to humans. IARC, Lyon, France, 1985;36:101-32.
130. Feron VJ, Kruysse A, Woutersen RA. Respiratory tract tumours in hamsters exposed to acetaldehyde vapour alone or simultaneously to benzo[a]pyrene or diethylnitrosamine. Eur J Cancer Clin Oncol. 1982;18:13-31.
131. Woutersen RA, Appelman LM, Van Garderen-Hoetmer A, Feron VJ. Inhalation toxicity of acetaldehyde in rats. III. Carcinogenicity study. Toxicology. 1986;41:213-31.
132. Bosron WF, Li TK. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases and their relationship to alcohol metabolism and alcoholism. Hepatology 1986;6(3):502-10.
133. Higuchi S, Matsushita S, Muramatsu T, Murayama M, Hayashida M. Alcohol and aldehyde dehydrogenase genotypes and drinking behavior in Japanese. Alcohol Clin Exp Res 1996;20(3):493-7.
134. Borràs E, Coutelle C, Rosell A, Fernández-Muixi F, Broch M, Crosas B, Hjelmqvist L, Lorenzo A, Gutiérrez C, Santos M, et al. Genetic polymorphism of alcohol dehydrogenase in Europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology 2000;31:984-9.
135. McCarver DG, Thomasson HR, Martier SS, Sokol RJ, Li T-K. Alcohol dehydrogenase-2*3 allele protects against alcohol-related birth defects among African Americans. J Pharmacol Exp Ther 1997;283:1095-1101.
136. Ehlers CL, Gilder DA, Harris L, Carr L. Association of the ADH2*3 allele with a negative family history of alcoholism in African American young adults. Alcohol Clin Exp Res 2001;25:1773-1777.
137. Whitfield JB. Meta-analysis of the effects of alcohol dehydrogenase genotype on alcohol dependence and alcoholic liver disease. Alcohol 1997;32(5):613-9.
138. Carr LG, Xu Y, Ho WH, Edenberg HJ. Nucleotide sequence of the ADH2(3) gene encoding the human alcohol dehydrogenase beta 3 subunit. Alcohol Clin Exp Res. 1989;13(4):594-6.
139. Harty LC, Caporaso NE, Hayes RB, Winn DM, Bravo-Otero E, Blot WJ, Kleinman DV, Brown LM, Armenian HK, Fraumeni JF Jr, et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst 1997;89:1698-705.
140. Coutelle C, Fleury B, Quattrocchi P, Chambrin H, Iron A, Couzigou P, Cassaigne A. Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathine S-transferase M1 polymorphism. Hum. Genet. 1997;99 (3):319-25.
141. Visapää JP, Götte K, Benesova M, Li JJ, Homann N, Conradt C, Inoue H, Tisch M, Hörmann K, Väkeväinen S, Salaspuro M, Seitz HK. Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 3*1-Allel possibly due to salivary acetaldehyde. Gut 2004;53(6):871-6.
142. Olshan AF, Weissler MC, Watson MA, Bell DA. Risk of head and neck cancer and the alcohol dehydrogenase 3 genotype. Carcinogenesis 2001;22:57-61.
143. Sturgis EM., Dahlstrom KR, Guan Y, Eicher SA, Strom SS, Spitz MR, Wei Q. Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx. Cancer Epidemiology, Biomarkers and Prevention 2001;10:273-275.
144. Brennan P, Lewis S, Hashibe M, Bell DA, Boffetta P, Bouchardy C, Caporaso N, Chen C, Coutelle C, Diehl SR, et al. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: A HUGE review. Am J Epidemiol 2004;159:1-16.
145. Yoshida A, Huang IY, Ikawa M. Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc Natl Acad Sci USA. 1984;81(1):258-61.
146. Wall TL, Thomasson HR, Schuckit MA, Ehlers CL. Subjective feelings of alcohol intoxication in Asians with genetic variations of ALDH2 alleles. Alcohol Clin Exp Res 1992;16(5):991-5.
147. Goedde HW, Agarwal DP, Fritze G, Meier-Tackmann D, Singh S, Beckmann G, Bhatia K, Chen LZ, Fang B, Lisker R, et al. Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet 1992;88:344-6.
148. Higuchi S, Matsushita S, Muramatsu T, Takagi S, Hayashida, M. Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. Am J Psychiatry 1995;b152:1219-21.
149. zur Hausen H. Papillomavirus infection - a major cause of human cancers. Biochim Biophys Acta 1996;1288(2):55-78.
150. International Agency for Research on Cancer (IARC) Human papillomaviruses. IARC Monograph on the evaluation of carcinogenic risks of chemicals to humans. IARC, Lyon, France 2005;90.
151. Steenbergen RD, Hermsen MA, Walboomers JM, Joenje H, Arwert F, Meijer CJ, Snijders PJ. Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 1995;55(22):5465-71.
152. Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH. Human papillomavirus and risk of oral cancer. Laryngoscope 1998;108(7):1098-103.
153. Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, Oggionni M, Rossini C, Cantù G, Squadrelli M, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006;24(36):5630-6.
154. Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X, Shyr Y, Murphy BM, Cmelak AJ, Burkey BB, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 2006;12(3 Pt 1):701-9.
155. Wentzensen N, Vinokurova S, von Knebel Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 2004;64(11):3878-84.
156. Werness BA, Levine AJ, Howley PM. Association of human papilloma virus type 16 and 18 E6 proteins with p53. Science 1990;248(4951):76-9.
157. Havre PA, Yuan J, Hedrick L, Cho KR, Glazer PM. p53 inactivation by HPV E6 results in increased mutagenesis in human cells. Cancer Res 1995;55(19):4420-4.
158. Dyson N, Howley PM, Münger K, Harlow E. The human papillomavirus 16 E7 protein is able to bind the retinoblastoma gene product. Science 1989;243(4893):934-7.
159. Boyer SN, Wazer DE, Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 1996;56(20):4620-4.
160. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L, Cho KR. Human papillomavirus 16 E6 expression disrupts the p53 -mediated cellular response to DNA damage. Proc Natl Acad Sci.U.S.A. 1993;90(9):3988-92.
161. Snijders PJF, van den Brule AJC, Meijer CJLM, Walboomers JMM. Papillomaviruses and cancer of the upper digestive and respiratory tracts. Curr Topics Microbiol Immunol 1994;186:177-98.
162. Ostwald C, Müller P, Barten M, Rutsatz K, Sonnenburg M, Milde-Langosch K, Loning T. Human papillomavirus DNA in oral squamous cell carcinoma and normal mucosa. J Oral Pathol Med 1994;23(5):220-5.
163. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997;79(3):595-604.
164. Steenbergen RD, Hermsen MA, Walboomers JM, Joenje H, Arwert F, Meijer CJ, Snijders PJ. Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 1995;55(22):5465-71.
165. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467-75.
166. Liu X, Han S, Baluda MA, Park NH. HPV16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes. Oncogene 1997;14(19):2347-53.
167. Mao E-J, Schwartz SM, Daling JR, Oda D, Tickman L, Beckmann AM. Human papilloma viruses and p53 mutations in normal pre-malignant and malignant oral epithelia. Int J Cancer 1996;69(2):152-8.
168. Haraf DJ, Nodzenski E, Brachman D, Mick R, Montag A, Graves D, Vokes EE, Weichselbaum RR. Human papilloma virus and p53 in head and neck cancer, clinical correlates and survival. Clin Cancer Res 1996;2(4):755-62.
169. Fouret P, Monceaux G, Temam S, Lacourreye L, St Guily JL. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg 1997;123(5):513-6.
170. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck cancer in non-smokers, a distinct clinical and molecular entity. Laryngoscope 1999;109(10):1544-51.
171. Koch WM, McQuone S. Clinical and molecular aspects of squamous cell carcinoma of the head and neck in the nonsmoker and nondrinker. Curr Opin Oncol 1997;9(3):257-61.
172. Báez A, Almodóvar JI, Cantor A, Celestin F, Cruz-Cruz L, Fonseca S, Trinidad-Pinedo J, Vega W. High frequency of HPV16-associated head and neck squamous cell carcinoma in the Puerto Rican population. Head Neck 2004;26(9):778-84.
173. Chiba I, Shindoh M, Yasuda M, Yamazaki Y, Amemiya A, Sato Y, Fujinaga K, Notani K, Fukuda H. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous carcinomas of the oral cavity. Oncogene 1996;12:1663-68.
174. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Helbig M, Dietz A, Weidauer H, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998;58:5-13.
175. Snijders PJ, Scholes AG, Hart CA, Jones AS, Vaughan ED, Woolgar JA, Meijer CJ, Walboomers JM, Field JK. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer 1996;66:464-9.
176. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx, a radiosensitive subgroup of head and neck carcinoma. Cancer 2001;92(4):805-13.
177. El-Mofty SK, Lu DW. (2003) Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 2003;27(11):1463-70.
178. Hafkamp HC, Manni JJ, Speel EJ. Role of human papillomavirus in the development of head and neck squamous cell carcinomas. Acta Otolaryngol 2004;124(4):520-6.
179. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356(19):1944-56.
180. Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 2001;125(1):1-9.
181. Jenison SA, Yu, X-p, Valentine J.M, Koutsky LA, Christiansen AE, Beckmann AM, Galloway DA. Evidence of prevalent genital-type human papillomavirus infection in adults and children. J Infect Dis 1990;162(1):60-9.
182. Treadwell P. Sexually transmitted diseases in neonates and infants. Semin Dermatol 1994;13(4):256-61.
183. Pao CC, Tsai PL, Chang YL, Hsieh TT, Jin JY. Non-sexual papillomavirus transmission route. Lancet 1992;339(8807):1479-80.
184. Smith EM, Johnson SR, Cripe T, Perlman S, McGuinness G, Jiang D, Cripe L, Turek LP. Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev 1995;19(2):196-205.
185. Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D, Haugen TH, Turek LP. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004;108(5):766-72.
186. Furniss CS, McClean MD, Smith JF, Bryan J, Nelson HH, Peters ES, Posner MR, Clark JR, Eisen EA, Kelsey KT. Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer 2007;120(11):2386-92.
187. International Agency for Research on Cancer (IARC). Strong acid mists and some other industrial exposures. IARC Monograph on the evaluation of carcinogenic risks of chemicals to humans. IARC, Lyon, France. 1992;54.
188. Wynder EL, Covey LS, Mabuchi K, Mushinski M. Environmental factors in cancer of the larynx: a second look. Cancer 1976;38:1591-601.
189. Easton DF, Peto J, Doll R. Cancers of the respiratory tract in mustard gas workers. Br J Ind Med 1988;45:652-9.
190. Brown LM, Mason TJ, Pickle LW, Stewart PA, Buffler PA, Burau K, Ziegler RG, Fraumeni JF Jr. Occupational risk factors for laryngeal cancer on the Texas Gulf Coast. Cancer Res 1988;48:1960-4.
191. Gustavsson P, Jakobsson R, Johansson H, Lewin F, Norell S, Rutkvist LE. Occupational exposures and squamous cell carcinoma of the oral cavity, pharynx, larynx, and oesophagus: a case-control study in Sweden. Occup Environ Med 1998;55:393-400.
192. Laforest L, Luce D, Goldberg P, Bégin D, Gérin M, Demers PA, Brugère J, Leclerc A. Laryngeal and hypopharyngeal cancers and occupational exposure to formaldehyde and various dusts: a case-control study in France. Occup Environ Med 2000;57:767-73.
193. Berrino F, Richiardi L, Boffetta P, Estève J, Belletti I, Raymond L, Troschel L, Pisani P, Zubiri L, Ascunce N, Gub́eran E, Tuyns A, Terracini B, Merletti F, Milan JEM Working Group. Occupation and larynx and hypopharynx cancer: a job-exposure matrix approach in an international case-control study in France, Italy, Spain and Switzerland. Cancer Causes Control 2003;14:213-23.
194. Purdue MP, Järvholm B, Bergdahl IA, Hayes RB, Baris D. Occupational exposures and head and neck cancers among Swedish construction workers. Scand JWork Environ Health 2006;32(4):270-5.
195. Shangina O, Brennan P, Szeszenia-Dabrowska N, Mates D, Fabíanov́a E, Fletcher T, t'Mannetje A, Boffetta P, Zaridze D.Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. Am J Epidemiol 2006;164(4):367-75.
196. Foulkes WD, Brunet JS, Sieh W, Black MJ, Shenouda G, Narod SA. Familial risks of squamous cell carcinoma of the head and neck, retrospective case-control study. Br Med J 1996;313(7059):716-21.
197. Schantz SP, Byers RM, Goepfert H, Shallenberger RC, Beddingfield N. The implication of tobacco use in the young adult with head and neck cancer. Cancer 1988;62(7):1374-80.
198. Puga A, Nebert DW, McKinnon RA, Menon AG. Genetic polymorphisms in human drug metabolizing enzymes, potential uses of reverse genetics to identify genes of toxicological relevance. Crit Rev Toxicol 1997;27(2):199-222.
199. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Øgreid D, Ulvik A, Vu P, Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997;18(7):1285-9.
200. Cheng L, Sturgis EM, Eicher SA, Char D, Spitz MR, Wei Q. Glutathione-stransferase polymorphisms and risk of squamous cell carcinoma of the head and neck. Int J Cancer 1999;84(3):220-4.
201. Sancer A. DNA repair in humans. Annu Rev Genet 1995;29:69-105.
202. Li D, Wang M, Cheng L, Spitz MR, Hittelman WN, Wei Q. In vitro induction of benzo[a]pyrene diol epoxide-induced DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res 1996;56(16):3638-41.
203. Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, Clayman GL, Strom SS, Spitz MR, Wei Q. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999;120(11):2125-9.
204. Sturgis EM, Zheng R, Li L, Castillo EJ, Eicher SA, Chen M, Strom SS, Spitz MR, Wei Q. XPD/ERCC2 polymorphisms and risk of head and neck cancer, a case-control analysis. Carcinogenesis 2000;21(12):2219-23.
205. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarkers Prev 1997;6(9):733-43.
206. Trizna Z, Clayman GL, Spitz MR, Briggs KL, Goepfert H. Glutathione S-transferase genotypes as risk factors for head and neck cancer. Am J Surg 1995;170:499-505.
207. Jahnke V, Matthias C, Fryer A, Strange R. Glutathione S-transferase and cytochrome-P450 polymorphism as risk factors for squamous cell carcinoma of the larynx. Am J Surg 1996;172:671-3.
208. Sato M, Sato T, Izumo T, Amagasa T. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 1999;20(10):1927-31.
209. Hung HC, Chuang J, Chien YC, Chern HD, Chiang CP, Kuo YS, Hildesheim A, Chen CJ.Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1;environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 1997;6(11):901-5.
210. Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C, Wild N, Leopard P, Bell DA, Jones P, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 1996;17(4):881-4.
211. Park JY, Muscat JE, Ren Q, Schantz SP, Harwick RD, Stern JC, Pike V, Richie JP Jr, Lazarus P. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev 1997;6(10):791-7.
212. Katoh T. The frequency of glutathione-S-transferase M1 (GSTM1) gene deletion in patients with lung and oral cancer. Jpn J Ind Health 1994;36(6):435-9.
213. Chen C, Ricks S, Doody DR, Fitzgibbons ED, Porter PL, Schwartz SM. N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk. Carcinogenesis 2001;22(12):1993-9.
214. Majumder M, Sikdar N, Ghosh S, Roy B. Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer 2007;120(10):2148-56.
215. Broughton BC, Steingrimsdottir H, Lehmann AR. Five polymorphisms in the coding sequence of the xeroderma pigmentosum group D gene. Mutat Res 1996;362:209-11.
216. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998;58(4):604-08.
217. Olshan AF, Watson MA, Weissler MC, Bell DA. XRCC1 polymorphisms and head and neck cancer. Cancer Lett 2002;278:181-6.
218. Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, Clayman GL, Strom SS, Spitz MR, Wei Q. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999;20:2125-9.
219. Tae K, Lee HS, Park BJ, Park CW, Kim KR, Cho HY, Kim LH, Park BL, Shin HD. Association of DNA repair gene XRCC1 polymorphisms with head and neck cancer in Korean population. Int J Cancer 2004;211:805-8.
220. Ankathil R, Mathew A, Joseph F, Nair MK. Is oral cancer susceptibility inherited? Report of five oral cancer families. Eur J Cancer B Oral Oncol 1996;32B(1):63-7.
221. Copper MP, Jovanovic A, Nauta JJ, Braakhuis BJ, de Vries N, van der Waal I, Snow GB. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1995;121(2):157-60.
222. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cycling D/CDK4. Nature 1993;366:704-7.
223. Cobrinik D, Dowdy SF, Hinds PW, Mittnacht S, Weinberg RA. The retinoblastoma protein and the regulation of cell cycling. Trends Biochem Sci 1992;17:312-5.
224. Olshan AF, Weissler MC, Pei H, Conway K, Anderson S, Fried DB, Yarbrough WG. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene 1997;14(7):811-8.
225. Jares P, Fernandez PL, Nadal A, Cazorla M, Hernández L, Pinyol M, Hernández S, Traserra J, Cardesa A, Campo E. p16MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx. Oncogene 1997;15(12):1445-53.
226. Lang JC, Tobin EJ, Knobloch TJ, Schuller DE, Bartynski KJ, Mountain RE, Nicholson R, DeYoung BR, Weghorst CM. Frequent mutation of p16 in squamous cell carcinoma of the head and neck. Laryngoscope 1998;108(6):923-8.
227. Nakahara Y, Shintani S, Mihara M, Ueyama Y, Matsumura T. High frequency of homozygous deletion and methylation of p16(INK4A) gene in oral squamous cell carcinomas. Cancer Lett 2001;163(2):221-8.
228. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 1994;8(1):23-6.
229. Whelan AJ, Bartsch D, Goodfellow PJ. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med 1995;333(15):975-7.
230. Yarbrough WG, Aprelikova O, Pei H, Olshan AF, Liu ET. Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele. J Natl Cancer Inst 1996;88(20):1489-91.
231. Yu KK, Zanation AM, Moss JR, Yarbrough WG. Familial head and neck cancer: molecular analysis of a new clinical entity. Laryngoscope 2002;112(9):1587-93.
232. Prime SS, Thakker NS, Pring M, Guest PG, Paterson IC. A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma. Oral Oncol 2002;38(2):216-7.
233. Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ. Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2007;69(4):218-25.
234. Reed K, Ravikumar TS, Gifford RR, Grage TB. The association of Fanconi's anemia and squamous cell carcinoma. Cancer 1983;52(5):926-8.
235. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003;101:822-6.